A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin icodec; Drug: Insulin glargine Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2020 Category: Research Source Type: clinical trials
Investigational, Once-Weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-Daily Insulin Glargine U100 in Phase 2 Trial
PLAINSBORO, N.J., June 14, 2020 /PRNewswire/ -- Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analog. In the trial, adults with type 2 diabetes... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 14, 2020 Category: Pharmaceuticals Source Type: clinical trials
Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan
Conditions: Type1diabetes; Fasting; Insulin Intervention: Other: Timing of taking insulin Sponsor: King Abdullah International Medical Research Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2020 Category: Research Source Type: clinical trials
